Smith & Nephew plc (SN.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:49PM BST
| Previous Close | 985.60 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 0.00 - 0.00 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 3,724,812 |
| Market Cap | 8.715B |
| Beta (5Y Monthly) | 0.51 |
| PE Ratio (TTM) | 41.53 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.30 (3.04%) |
| Ex-Dividend Date | Mar 28, 2024 |
| 1y Target Est | N/A |
- The Guardian
Nearly half of Smith & Nephew investors revolt against CEO pay rise
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
- Simply Wall St.
With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
- Insider Monkey
Here’s Why You Should Invest in Smith & Nephew plc (SNN)
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]
© 2024 Yahoo. All rights reserved.